AI assistant
Sending…
Pluri Inc. — Share Issue/Capital Change 2019
Jul 24, 2019
6990_rns_2019-07-24_d0770e42-4ae3-4c9f-934e-30e43a45053f.htm
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Pluristem Announces One-for-Ten Reverse Split of its Common Shares false
| �������� ��������� ���� | 2 380 |
| PLURISTEM THERAPEUTICS INC | |
| Corporation no: C12337-2001 | 8544 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 24/07/2019 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2019-02-063855 | Time of broadcast: 09:38 09:16:07 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onPluristem Announces One-for-Ten Reverse Split of its Common Shares
PSTI_-_Revere_Stock_Split_final_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 25/06/2019 |
| Address: Matam Park 5 , Haifa 31905 ISRAEL , Tel: 074-7107171 , Fax: 074-7107172 | |
| E-mail address: [email protected] Company site: www.pluristem.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Aberman Zalman Position of Signatory in the reporting corporation: Chairman Of The Board & CEO Name of Employer Company: | |
| Address: Matam Park 20 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7107172 E-mail: [email protected] 2 | |
More from Pluri Inc.
Report Publication Announcement
2026
May 14
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 23
Report Publication Announcement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Capital/Financing Update
2026
Mar 27